Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced its participation at the Piper Jaffray 25 th Annual Healthcare Conference to be held on December 3-4, 2013 at the New York Palace in New York, NY.
|Acceleron speaker:||John Knopf, Ph.D., Chief Executive Officer of Acceleron|
|Date:||Tuesday, December 3, 2013|
|Time:||3:00 PM (EST)|
|Location:||New York Palace Hotel, New York, NY|
For more information, please visit www.acceleronpharma.com.